...
首页> 外文期刊>Hepato-gastroenterology. >Surgical treatment of liver metastases from breast cancer.
【24h】

Surgical treatment of liver metastases from breast cancer.

机译:乳腺癌肝转移的外科治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND/AIMS: The resection of colorectal liver metastases is currently a well accepted and effective treatment. In the past decade liver metastases of breast cancer have been treated more frequently by surgical intervention. METHODOLOGY: The authors retrospectively studied the data of 17 operated patients, and investigated the clinical features of liver metastases, lymph node involvement of primary tumor, the indications of operations, and early and late results of the treatment. RESULTS: The solitary metastasis and demarcated multiple metastases, which seemed (by CT scan) to be operable by Ro resection were among the surgical indications. Different segment resections, 3 laparoscopic resections and one hemihepatectomy were performed. There were no deaths in the perioperative period, though there were two minor postoperative complications in two cases. All patients received chemotherapy. By follow-up, three breast cancer patients died, whose average survival rate was 19.25 months. The other patients' average follow-up time was 15.17 months, without relapse. CONCLUSIONS: In conclusion it appears that in selected cases resection of liver metastases can be safely performed and the survival rate is reasonable.
机译:背景/目的:结直肠癌肝转移的切除术是目前公认的有效方法。在过去的十年中,通过外科手术更频繁地治疗了乳腺癌的肝转移。方法:作者回顾性研究了17例手术患者的数据,并调查了肝转移的临床特征,原发肿瘤的淋巴结受累,手术指征以及早期和晚期治疗结果。结果:孤立的转移和划定的多处转移(通过CT扫描)似乎可以通过Ro切除术进行手术,这是手术的适应症。进行了不同的节段切除,3例腹腔镜切除和1例半肝切除术。围手术期无死亡病例,尽管有2例发生了两次轻微的术后并发症。所有患者均接受了化疗。通过随访,三名乳腺癌患者死亡,其平均生存期为19.25个月。其他患者的平均随访时间为15.17个月,无复发。结论:总的来说,在某些情况下,可以安全地切除肝转移灶,生存率是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号